Company:
News and Publications
Knowledge and perspectives are most powerful when they are communicated to many. Through the depth of our work and wide industry exposure, Putnam Associates uncovers the strategic questions and commercialization challenges that confront drugs, diagnostics and biomedical products. Our news and publications address these issues and share the information that leads to better-informed decisions. Learn more about our growth, ideas and successes:
News:
Interviews
The Boston Globe quoted Kevin Gorman in an article entitled, “Sanofi Taps Meeker as Genzyme CEO,” October 25, 2011, by Robert Weisman
Specialty Pharmacy News interviewed and quoted John Gordon and Kevin Gorman an article, “Switching Transplant Patients from Prograf to Generic Drug Offers Array of Challenges,” October 2011, by Angela Maas, Managing Editor
Boston Business Journal, interviewed Ken Beers on September 13, 2011 and quoted him in an article, “Superbugs Fuel Work at Smaller Drug Firms,” September 16, 2011, by Julie Donnelly
The Wall Street Journal (wsj.com), interviewed and quoted Kevin Gorman in an article entitled, “What is a ‘Pharmacy Benefit Manager?’” July 21, 2011, by Thomas Gryta
The Pink Sheet interviewed and quoted John Gordon in an article entitled, “Employers Eye CER To Improve Employee Health, Lower Costs – NPC Survey,” July 11, 2011, by Gregory Twachtman
The Boston Globe interviewed and quoted John Gordon in an article
entitled, “Biotechs are Spending Less on Drug Discovery,” June 14, 2011,
by Robert Weisman
The Wall Street Journal interviewed and quoted Kevin Gorman in an article entitled, “Sanofi to Help Genzyme Resolve Manufacturing Woes,” February 16, 2011, by Thomas Gryta
Boston Business Journal interviewed and quoted Eric Auger in an article, “Looming Competition Takes Toll on Momenta Shares,” February 4-10, 2011, by Julie Donnelly
The Boston Globe interviewed and quoted Kevin Gorman in an article entitled, "Industry Consolidation Will Continue," January 2, 2011, by Robert Weisman
The Boston Globe interviewed and quoted Kevin Gorman in an article entitled, "Biotech Firms Squeezed by Economy and Hungry Giants," November 6, 2010, by Robert Weisman
Specialty Pharmacy News published Kevin Gorman’s and Kenneth Beers’ comments in articles entitled, "FDA Approves New Oral MS Drug, Gives Patients Long-Sought Therapeutic Option" and “Payers Are Reviewing Gilenya; Coverage Limitations Are Likely,” October 2010, by Angela Maas
Pharmaceutical Commerce published Richard Tinsley’s article entitled, “How to Think About Companion Diagnostics,” in their Op-Ed section, August 2010 issue
The Boston Globe interviewed and quoted Kevin Gorman in the article, “The Side Effects of a Genzyme Deal: Already Benefiting from Firm’s Production Woes, Rivals Foresee Wider Opening,” August 12, 2010, by Robert Weisman
Thomson Reuters interviewed and quoted Kevin Gorman in an article entitled, "Deal Talk: White Knight Could Be Elusive for Genzyme,” July 30, 2010, by Toni Clarke, Correspondent
The Wall Street Journal, print (front page of "Marketplace" section) and online editions, interviewed and quoted Kevin Gorman on Amgen and Prolia in an article entitled, "Amgen Bets on Osteoporosis Drug to Revive Its Flagging Growth," June 4, 2010, by Ron Winslow
Specialty Pharmacy News interviewed and quoted Matt Riordan in the articles by Angela Maas (June 2010):
- "Long-Awaited Prostate Cancer Therapy Approved, but Use May Be Limited Initially"
- "Will Provenge Price Tag Prompt Closer Look at Benefit Designs?"
The Boston Globe interviewed and quoted John Gordon in an article, "Buyout Will Give Life Sciences Firm Foothold in China; Charles River Labs to Expand into Drug Discovery Services," May 25, 2010, by Robert Weisman
Specialty Pharmacy News interviewed and quoted Richard Tinsley and Sam Kelkar in articles by Angela Maas:
- "While Not Easy, Manufacturing Process for Biologics Has Improved Tremendously" (May 2010)
- "Health Reform Update: With Biosimilar Law Finally Passed, Payers Need to Dig In Now, Keep Eye on FDA" (April 2010)
Specialty Pharmacy News interviewed and quoted Eric Auger and Matt Riordan in an article, "Waste Control, Assay Management Can Help Temper Hemophilia Costs," March 2010, by Angela Maas
Mass High Tech interviewed and quoted Paul Bogorad in an article entitled, "Biotechs Find Progress in Vaccine Market," February 3, 2010, by Julie Donnelly
BIO SmartBrief interviewed and quoted Paul Bogorad in an article entitled, "Biotechs Find Progress in Vaccine Market," February 3, 2010, by Julie Donnelly
FierceVaccines quoted Paul Bogorad in an article entitled, "Pharma Turns to Small Developers for New Vax Tech," February 3, 2010, by John Carroll (story picked up from Mass High Tech, February 3, 2010)
FierceBiotech quoted Paul Bogorad in an article entitled, "Paul Bogorad at Putnam Associates is bullish about the vaccine business," February 3, 2010, by John Carroll (story picked up from Mass High Tech, February 3, 2010)
VaccineNews.com quoted Paul Bogorad in an article entitled, "Biotech Companies Find Progress in Vaccine Market," February 3, 2010, by Tina Redlup (story picked up from Mass High Tech, February 3, 2010)
Boston Business Journal interviewed and quoted Kevin Gorman in an article entitled, "Mass. Biotechs Eye Opening IPO Window," January 15-21, 2010, by Julie Donnelly
Mass High Tech quoted Kevin Gorman in an article entitled, "Biotech IPOs on the Rise in Mass," January 15, 2010, by Julie Donnelly
FierceBiotech quoted Kevin Gorman in the article, "Does an M&A Flurry Presage a Blizzard of New Deals?" November 11, 2009, by John Carroll
The Boston Globe interviewed and quoted Kevin Gorman in the article, "Looking for Partners: French Drug Maker Says It's Eager to Work with Boston-Area Companies," November 11, 2009, by Robert Weisman
The Boston Globe interviewed and quoted Kevin Gorman in the article, "Buying Binge Hits Biotech Firms," September 22, 2009, by Robert Weisman
FierceBiotech quoted Kevin Gorman in the article, "Does an M&A Flurry Presage a Blizzard of New Deals?" September 22, 2009, by John Carroll
The Wall Street Journal Online interviewed and quoted Kevin Gorman in an article entitled, "Amgen Hiring Mobile Reps in Building Bone Drug Sales Force," September 17, 2009, by Thomas Gryta
The Boston Globe interviewed and quoted Kevin Gorman in the article entitled, "FDA Seeks Contingency Details from Genzyme / Availability of Firm's Orphan Drugs is Concern for Agency," August 13, 2009, by Robert Weisman
The Boston Globe interviewed Kevin Gorman and quoted him on Epix Pharmaceuticals' bankruptcy in the article entitled, "Epix Pharmaceuticals is Latest Biotech to Fall," July 22, 2009, by Robert Weisman
The Boston Globe interviewed and quoted Domenick Bertelli on Biopure bankruptcy in the article entitled, "Biopure Files Chapter 11, Plans Sale," July 18, 2009, by D.C. Denison
Boston Business Journal interviewed and quoted Kevin Gorman in the article "Bio Companies Come to Grips with Gift Ban," June 26-July 2, 2009, by Julie Donnelly
The Boston Globe interviewed Kevin Gorman and Domenick Bertelli and quoted them in a front-page feature article entitled, "Virus Shuts Genzyme Plant, Holds Up Drugs for 8,000," June 17, 2009, by Erin Ailworth and Robert Weisman
Boston Business Journal published Domenick Bertelli's comments on the diabetes and obesity market in "Bay State Biotech Firms Targeting the Fat of the Land," June 5-11, 2009, by Julie Donnelly
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Some Early Efforts Under Obama Could Impact Specialty Pharmacy," November 2008
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Economic Downturn Hits Specialty Industry Hard; Stakeholder Responses Are Varied," November 2008
Interview with Kevin Gorman and Paul Bogorad in Drug Benefit News, "Removal of Ranbaxy Generic Rxsls Not Likely to Have Major Impact", October 3, 2008
Interview with Kevin Gorman in Drug Benefit News, "Weak Economy, Cash-Strapped Consumers May Take Toll on Pharmaceutical Benefits", October 3, 2008
Interview with Eric Auger and Ricky Joshi in Specialty Pharmacy News, "Psoriasis Can Have Significant Health Impact; Plan Understanding May Be Lacking," July 2008
Interview with Richard Tinsley and Paul Bogorad in Specialty Pharmacy News, "Multiple Copays, Management Tools May Influence Influence HIV/AIDS Patients' Compliance," April 2008
Interview with John Baskey in Pharmaceutical Commerce, "Generic Manufacturers Plan Aggressive Challenges of Branded Products During 2008-2016: Paragraph IV challenges already target 57% of potential remaining product sales," January-February 2008 issue
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Outlook 2008: HIV, Oncology are Among Areas That Will See Therapeutic Impact," January 2008
Interview with Eric Auger in Drug Benefit News, "First Genric Protonix Hits the Market; Plans, PBMs Expect Modest Savings at First," January 18, 2008
Speaking Engagements
John Gordon was a speaker on the panel entitled, “Regulatory Uncertainty,” at the MIT Sloan BioInnovations 2011 Annual Health Care Conference, held on Friday, March 4, 2011, 8:30 a.m. – 4:00 p.m. at Boston Marriott Cambridge Hotel, Kendall Square, Cambridge, MA
John Gordon was moderator and panelist at the Babson College 8th Annual Healthcare and Life Sciences Forum, February 10, 2011, on “Healthcare Technology Commercialization”
Kevin Gorman spoke as a panelist at the 2011 17th Annual Wharton Health Care Business Conference (www.whcbc.org), “Leadership in an Evolving Global Market,” held at Hyatt at The Bellevue in Philadelphia on February 24-25, 2011. His panel was entitled, “Life After Blockbusters.”
John Gordon was a panelist at Harvard Business School’s 2011 8th Annual Healthcare Conference, “The State of Healthcare Reform: Strategies, Challenges, Success,” January 29, 2011 on “Innovation and Risk Mitigation in Drug Development”
John Gordon was a moderator and speaker at Harvard Business School's 2010 7th Annual Healthcare Conference, "Policy Reform: An Inflection Point for Healthcare Management," January 30, 2010 on "How Will IP Shape Growth?"
Eric Auger was a speaker at the 2010 Pricing for New Bio-Pharmaceutical Products Conference (American Conference Institute), January 27, 2010 on "Managed Care Contracting for New Product Launches"
Paul Bogorad, Ph.D. was a speaker discussing healthcare comparative effectiveness reviews at the 2009 Healthcare Deal Making Summit, "Positioning the Healthcare Organization for an Era of Reform," September 21-22, 2009. Among the speakers were Senator Thomas Daschle and Senator Robert F. Bennett
Kevin J. Gorman, Managing Partner, was chair and panelist of "The Struggle to Maintain Global Market Access for Innovative Biologic Products: Strategic, Economic and Product Security Perspectives" at 2009 BIO (Biotechnology Industry Organization) International Convention, May 18-21, 2009
BioProcess International (March 2009) quoted Kevin Gorman in the chapter, "A World of Possibilities: Global/International Biotechnology Issues,"
on the struggle to maintain global market access for innovative biologic products including strategic, economic and product security perspectives,
the topic of the panel discussion which Mr. Gorman will chair at the 2009 BIO International Convention, Atlanta, May 18-21, 2009
Kevin J. Gorman was Speaker at Wharton's 2009 Health Care Business Conference, February 20, 2009
Forbes.com published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement." Knowledge®Wharton is the author of this article entitled, "Health Reform is Nigh," (March 5, 2009)
Knowledge@Wharton in the article, "'Major League, Middle Class Anxiety': Is the U.S. Closer to Universal Health Care?" (March 4, 2009) published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement"
Inflection Point Articles
Raising Orphans: A Refined Approach to Selecting and Developing Orphan Products
(Press Release)
How to Think About Companion Diagnostics: Seven Questions to Consider
(Press Release)
Leveraging Physician Segmentation to Develop Brand Strategy: Getting More From Physician Segmentation
Putnam Associates Reports on Leveraging Physician Segmentation to Develop Brand Strategy
Not Your Father's Generics: How A Rapidly Changing Global Generic Industry is Challenging Lifecycle Planning
Putnam Associates Reports on Rapidly Changing Generic Industry
US Managed Markets: Opportunities and Risks in the Emerging Appropriate Use Paradigm
Putnam Associates Study Finds Insurers Want More Prescription Drug Use
Alliance Management - Fix it Before it Breaks: Alliance Diagnostic and Repair
Nurse Practitioners and Physician Assistants: Often Untapped for Sales and Marketing Initiatives
20th Anniversary
In celebration of its 20th anniversary, Putnam Associates has published The First Twenty Years Are the Hardest: Two Decades in Healthcare Strategy, a collection of perspectives from a cross section of experts in healthcare
Putnam Associates Celebrates Its 20th Anniversary
Firm Rankings
For 2011, Vault again has recognized Putnam Associates as one of the Top 50 Strategy Consulting Firms
For 2010, Putnam Associates Named One of Top 50 Strategy Consulting Firms and One of 20 Best Firms to Work For
For the 5th Year in a Row, Putnam Associates named one of the top 50 Strategy Consulting Firms
Consulting Magazine Names Putnam Associates a Leader Among Nation's Firms
Promotions
Domenick Bertelli Promoted to Partner
For more information about our news and publications, email Kevin Gorman.